Sensible Biotechnologies
Sensible Biotechnologies is a company selected for NATO DIANA the 2025 cohort under the Human Health & Performance challenge area. It received the standard €100,000 non-dilutive Phase 1 grant.
Develops biosensor and biotechnology platforms for real-time health and environmental monitoring.
Standard DIANA Phase 1 grant. Phase 2 offers up to €300,000 for outstanding performers.
Part of NATO DIANA's network of 16 accelerator sites and 200+ test centres.
Facts
- Cohort
- 2025 Cohort
- Challenge area
- Human Health & Performance
- Country
- Not publicly verified
- Funding stage
- €100,000 non-dilutive grant
- Website
- sensible.bio
- Verification
- Not publicly verified
Sources and verification
Selection facts (cohort, challenge area, funding track) come from the DIANA 2025 cohort announcement (December 2024). Company descriptions are paraphrased from public company material. How we verify records is explained in the methodology. Data reviewed 2026-08-23.
Data reviewed 2026-08-23. See our methodology for sourcing and verification rules.